Latest Exact Sciences News & Updates

See the latest news and media coverage for Exact Sciences. We track all announcements, press releases, and industry mentions in real time, all in one place.

Exact Sciences

Cancer prevention, screening, and therapy guidance company

exactsciences.com

Headquarters: Madison, United States
Company type: Public company
Number of employees: 5,000–10,000
Industry: Biotechnology & Medical Research

Last updated September 21

Latest news about Exact Sciences

In short: Exact Sciences was acquired by Abbott for $23 billion and posted record 2025 revenue of $3.25 billion

Company announcements

July 7 Exact Sciences

Exact Sciences expands Cancerguard test access in Japan

The multi-cancer early detection test is now available to patients in Japan following a team effort.

May 27 Exact Sciences

Exact Sciences' Cologuard preferred in updated ACS guideline

The guideline also added blood tests for people unwilling or unable to complete preferred screening.

February 13 Exact Sciences

Exact Sciences achieves record 2025 revenue

Revenue grew 18% to $3.25B, with Screening and Precision Oncology both strong.

February 2 Exact Sciences

Exact Sciences applauds passage of MCED coverage legislation

The law establishes a Medicare coverage pathway for multi-cancer early detection tests, potentially expanding access to Cancerguard for millions.

Media coverage

September 21 Chippewa Health System

Exact Sciences misses Q4 expectations for earnings, beats for revenue

The company best known for its Cologuard colon cancer screening test posted a loss of $86 million, or $0.45 per share, on revenue of $878.4...

September 21 Medical Economics

Abbott to acquire Exact Sciences in $21 billion deal, aiming to lead in fast-growing cancer diagnostics market | Medical Economics

Deal is expected to accelerate innovation in cancer diagnostics and expand access to early detection tools at a time when global cancer rates continue to...

September 17 Ad Hoc News

The Abbott Laboratories stock reacts to the Exact Sciences acquisition and remains near its 52-week high

The Abbott Laboratories stock is in focus following the announced acquisition of Exact Sciences for a volume of approximately 21 billion USD on September 18, 2026. According to home exchange data, the share price is near 102...

August 17 Wisconsin State Journal

Abbott Labs to acquire Madison's Exact Sciences in $23 billion deal

The company will maintain its presence in Madison and CEO Kevin Conroy will remain "in an advisory role," said Zach Brandon, president of the Greater...

Never miss news about Exact Sciences

Track Exact Sciences and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Exact Sciences competitors & trending companies

Browse news for competitors to Exact Sciences and other trending companies.